Antigen-specific tolerance strategies for the prevention and treatment of autoimmune disease.
about
Regulation of adaptive immunity; the role of interleukin-10The aryl hydrocarbon receptor: a perspective on potential roles in the immune systemBreaking Free of Control: How Conventional T Cells Overcome Regulatory T Cell Suppression.Active suppression induced by repetitive self-epitopes protects against EAE developmentRestoring immune tolerance in neuromyelitis optica: Part IUnbalanced Immune System: Immunodeficiencies and AutoimmunityDefective autoimmune regulator-dependent central tolerance to myelin protein zero is linked to autoimmune peripheral neuropathyGeneration of gene-engineered chimeric DNA molecules for specific therapy of autoimmune diseases.A GMCSF-neuroantigen fusion protein is a potent tolerogen in experimental autoimmune encephalomyelitis (EAE) that is associated with efficient targeting of neuroantigen to APCMolecular mechanisms of T-cell receptor and costimulatory molecule ligation/blockade in autoimmune disease therapy.Immunotherapy of type 1 diabetes: where are we and where should we be going?Ethylenecarbodiimide-treated splenocytes carrying male CD4 epitopes confer histocompatibility Y chromosome antigen transplant protection by inhibiting CD154 upregulation.Intracerebral dendritic cells critically modulate encephalitogenic versus regulatory immune responses in the CNS.Promoting tolerance to proteolipid protein-induced experimental autoimmune encephalomyelitis through targeting dendritic cells.Sequential transcriptional changes dictate safe and effective antigen-specific immunotherapy.Virtual optimization of nasal insulin therapy predicts immunization frequency to be crucial for diabetes protection.DC expressing transgene Foxp3 are regulatory APC.Bone marrow stromal cell transplants prevent experimental enterocolitis and require host CD11b+ splenocytes.Prevention of "Humanized" diabetogenic CD8 T-cell responses in HLA-transgenic NOD mice by a multipeptide coupled-cell approachChallenges in the pursuit of immune tolerance.Tolerance induced by apoptotic antigen-coupled leukocytes is induced by PD-L1+ and IL-10-producing splenic macrophages and maintained by T regulatory cells.Structure, size, and solubility of antigen arrays determines efficacy in experimental autoimmune encephalomyelitis.Co-delivery of autoantigen and b7 pathway modulators suppresses experimental autoimmune encephalomyelitis.Codelivery of antigen and an immune cell adhesion inhibitor is necessary for efficacy of soluble antigen arrays in experimental autoimmune encephalomyelitisIn Vivo Induction of Functionally Suppressive Induced Regulatory T Cells from CD4+CD25- T Cells Using an Hsp70 Peptide.Breakdown in peripheral tolerance in type 1 diabetes in mice and humansImmune Tolerance Induction against Experimental Autoimmune Encephalomyelitis (EAE) Using A New PLP-B7AP Conjugate that Simultaneously Targets B7/CD28 Costimulatory Signal and TCR/MHC-II Signal.Diabetes tolerogenic vaccines targeting antigen-specific inflammationAntigenic Stimulation of Kv1.3-Deficient Th Cells Gives Rise to a Population of Foxp3-Independent T Cells with Suppressive Properties.Platelets contribute to the pathogenesis of experimental autoimmune encephalomyelitis.Ethylenecarbodiimide-fixed donor splenocyte infusions differentially target direct and indirect pathways of allorecognition for induction of transplant toleranceImmune modulating peptides for the treatment and suppression of multiple sclerosis.Pathogenesis of NOD diabetes is initiated by reactivity to the insulin B chain 9-23 epitope and involves functional epitope spreading.Regulatory T cells that recognize a ubiquitous stress-inducible self-antigen are long-lived suppressors of autoimmune arthritisSENP1-mediated NEMO deSUMOylation in adipocytes limits inflammatory responses and type-1 diabetes progressionIntragraft CD11b(+) IDO(+) cells mediate cardiac allograft tolerance by ECDI-fixed donor splenocyte infusionsTargeting Treg signaling for the treatment of autoimmune diseasesInjectable, Pore-Forming Hydrogels for In Vivo Enrichment of Immature Dendritic Cells.Engineering antigens for in situ erythrocyte binding induces T-cell deletion.Myeloperoxidase Peptide-Based Nasal Tolerance in Experimental ANCA-Associated GN.
P2860
Q21131215-64F3B7C5-FEC6-4502-B04D-4787C80A58E2Q24338766-EECC3EDB-C9C5-4033-8C64-6BB3116FD448Q26744624-756E242D-27D5-4F1F-8F24-699B579CCACCQ27318065-30DDC5B6-071C-496D-9255-7CEB6B4939C0Q28072382-5F0D2659-21BD-4B89-8C13-081364E4003DQ28075911-C4D3A43F-0E4A-4577-BCFF-6B3B2770EA44Q28588498-1FA46030-9B0F-48A6-9602-44ED066A28E5Q33586280-FD172B7C-0158-4FE2-9F5A-CFC140153B74Q33694528-802AE441-D614-49EF-BE47-3EFD36773964Q33753720-EDC34896-DBF7-428B-8C7A-DE3B6FF84D03Q33815506-DBD36AA7-386E-4E47-A76F-85BCD0889C4BQ34103866-12211118-A691-4F77-BF19-3ED80B02E2DDQ34140567-011E471B-EA3B-4A06-BA17-58C0AF94D478Q34182445-A4DA6697-927B-44D5-A2AA-288BD6E85F9BQ34205503-DDF2400B-7317-4EFF-A873-B2F78F0E7DD1Q34355286-B16CC39B-54DF-4D98-9FFF-688B1E0A57E8Q34503547-7D67128C-8BBB-4B33-A115-827826BD5CB3Q34553368-F2BD9CD4-F222-44F5-9C0B-8BFF25FC37ADQ34718795-48928CEE-17E2-4A89-91C3-C009D9E477DDQ34974448-E0BE80BE-38B0-490A-9CEA-14AAEE64620DQ35175866-972C5394-1D88-449B-8C81-289186CCE26DQ35318199-7B5D117E-8B88-43C2-A4EA-39F85AC71CFCQ35318380-77FB9F04-2EC7-464F-9D2B-9C7DD85B4000Q35571156-8BAEBBEA-843B-4EBD-952C-12403EC9F26BQ35673344-742408A1-B0D8-4B06-89CF-47D387E06975Q35765731-A88B2644-83B9-4987-892A-203EF73CD0DFQ35794350-B2659260-C2BE-42B4-B57E-5C8FEE387AC0Q35887037-FDA3E231-3A1C-4452-914D-FE5A88324727Q35931778-F611C13B-59E2-43AA-8F75-2F23A185F8E6Q36055389-254C368C-B1D8-404B-9457-31CBBA23A68AQ36084033-8003D9F4-A481-4509-A29D-73CCD7EDB76BQ36151968-24C2B51B-31A6-4CF8-84DE-78D90D183005Q36209928-F0AEF211-8716-44E5-8999-5BA29165F485Q36212936-A68FE1E4-AC74-4E47-86F9-FDD55ECD2C83Q36325236-94E45DD3-2EE5-4C9A-8FFF-FE9217886A15Q36356879-BC2448D0-6ED8-4497-AB89-AD813C792F76Q36372616-869F829F-E829-4D2A-8F00-E4B81F1B8E25Q36470551-646B0463-D022-4E49-A304-7D40EA0D95A7Q36512070-86FE2991-19A1-40D5-8AF4-FABECA0768A9Q36514958-A80A5016-9E23-40BB-8291-7CFA3AFCED3B
P2860
Antigen-specific tolerance strategies for the prevention and treatment of autoimmune disease.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Antigen-specific tolerance str ...... eatment of autoimmune disease.
@ast
Antigen-specific tolerance str ...... eatment of autoimmune disease.
@en
type
label
Antigen-specific tolerance str ...... eatment of autoimmune disease.
@ast
Antigen-specific tolerance str ...... eatment of autoimmune disease.
@en
prefLabel
Antigen-specific tolerance str ...... eatment of autoimmune disease.
@ast
Antigen-specific tolerance str ...... eatment of autoimmune disease.
@en
P2093
P356
P1476
Antigen-specific tolerance str ...... eatment of autoimmune disease.
@en
P2093
Danielle M Turley
Joseph R Podojil
Stephen D Miller
P304
P356
10.1038/NRI2153
P577
2007-08-10T00:00:00Z